MMP-11 expression in early luminal breast cancer: associations with clinical, MRI, pathological characteristics, and disease-free survival.

Fiche publication

Date publication

mars 2024

Journal

BMC cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Dr ALPY Fabien , Pr CHENARD Marie-Pierre , Pr MATHELIN Carole , Dr TOMASETTO Catherine

Tous les auteurs :
Molière S, Lodi M, Leblanc S, Gressel A, Mathelin C, Alpy F, Chenard MP, Tomasetto C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38438841

Résumé

Early hormone-positive breast cancers typically have favorable outcomes, yet long-term surveillance is crucial due to the risk of late recurrences. While many studies associate MMP-11 expression with poor prognosis in breast cancer, few focus on early-stage cases. This study explores MMP-11 as an early prognostic marker in hormone-positive breast cancers.